LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/FDA Clears joimax’s Endoscopic-Assisted Fusion Cage
Company News

FDA Clears joimax’s Endoscopic-Assisted Fusion Cage

July 15, 2015 2 min read Premium comments

Advertisement

FDA Clears joimax’s Endoscopic-Assisted Fusion Cage
EndoLIF On-Cage Implant / Source: joimax GmbH
Secondary

German-based minimally invasive endoscopic spine surgery technology developer joimax GmbH has been cleared by the FDA to market the company’s Endoscopic Lumbar Interbody Fusion, or EndoLIF On-Cage: 3D-printed implant.

Enabling Fusion

In a July 13, 2015 press release, the company stated the new implant allows surgeons to use an inter-muscular approach, “similar to a mini transforaminal lumbar interbody fusion (TLIF), into the intervertebral disc, enabling endoscopic-assisted fusion.”

EndoLIF Implant

The implant consists of titanium alloy, produced with Electron Beam Melt (EBM) technology. The cage has a porous surface with diamond cell structure, providing an “optimal base for cell proliferation and bone growth.” Two large openings can be filled with autogenous bone to support the creation of a straight column for fusion.

The cage is designed to be used with supplemental posterior fixation, such as the joimax Percusys percutaneous pedicle screw-rod system. According to the company, cage implantation can be performed with a posterior or postero-lateral approach, either using an open or endoscopic-assisted method.

Surgical Site Access

Access to the surgical site is one the main challenges when using endoscopic surgical methods.

Advertisement

Two German spine specialists, Ralf Wagner, M.D. of the LIGAMENTA Spine Center in Frankfurt and Bernd Illerhaus, M.D., at Datteln/Recklinghausen, have performed more than 200 out of 600 EndoLIF procedures in Europe, according to the company. “The access is dura and nerve-gentle, preserves the dorsal bony structures and we can avoid scar tissue because of the stepwise tissue dilation, ” said Dr. Illerhaus.

Yeung: “Elevate Interest”

Anthony Yeung, M.D., one of the most well-known proponents and teachers of endoscopic spine procedures, has made no secret of his caution of fusing the spine. But Dr. Yeung told OTW that he congratulates joimax for this implant, which he says “will elevate the interest in transforaminal endoscopic surgery, including stabilization as part of a least invasive and most effective technique.”

“This is another iteration of the transforaminal endoscopic approach to augment the least invasive T-Lif approaches already on the market, specifically iO-Lif implants by Amendia, Globus, and others. There are differences in cage structure and design offered by different companies. It comes with the desirable knowledge and training for transforaminalplasty, a partial decompression of the lateral facet to make room for cage implantation without sacrificing the whole facet and destabilizing the spine, thus necessitating posterior stabilization. The transforaminal fusion approach will continue to evolve using smaller expandable cages with larger footprints that will create enough anterior stability to eliminate the need for posterior instrumentation.”

Ultimately, he says a significant number of fusions can be decreased by “endoscopic decompression, ablation, dynamic stabilization and even nucleus augmentation before fusion.”

However, he adds that there are pitfalls and complication risks to the transforaminal approach consisting of anatomic nerve variations and patho-anatomy that increase complication risk, “but can be overcome with proper training.”

More Gentle Techniques to Follow

“With the EndoLIF program, joimax offers a complete endoscopic-assisted solution for spinal stabilization and fusion. In the future, we will be able to treat patients with even more gentle techniques, ” said Wolfgang Ries, CEO and founder of joimax. “Our next development will be an EndoLIF Cage on the basis of our iLESSYS Delta system for posterior lumbar inter-body fusion (PLIF).”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy